clinical challenges in the patient with relapsed multiple myeloma

23
Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Upload: snow

Post on 24-Feb-2016

85 views

Category:

Documents


0 download

DESCRIPTION

Clinical Challenges in the Patient With Relapsed Multiple Myeloma. Multiple Myeloma How to decide what to do at first relapse? . Early Relapsed Multiple Myeloma Carfilzomib and Pomalidomide. Relapsed Multiple Myeloma Try to use therapies for as long as they work. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Page 2: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 3: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 4: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 5: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 6: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 7: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Multiple MyelomaHow to decide what to do at first relapse?

Page 8: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 9: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 10: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 11: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Early Relapsed Multiple MyelomaCarfilzomib and Pomalidomide

Page 12: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Relapsed Multiple Myeloma Try to use therapies for as long as they

work.

Page 13: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Early Relapsed Multiple MyelomaDuration of Therapy

Page 14: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Duration of Therapy Try to treat for at least 8 cycles or to best

response and not until progression.

Page 15: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Duration of Therapy Patients with short second remission or

high-risk disease should be treated continuously until progression.

Page 16: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Early Relapsed Multiple MyelomaRole and Timing of 2nd HDT/ASCT

Page 17: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

2nd HDT/ASCT at RelapseUse for patients who had at least 3-year

remission after first HDT/ASCT, and follow by alternative maintenance therapy to

what they had previously.

Page 18: Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Page 19: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Abbreviations

Page 20: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Abbreviations (cont)

Page 21: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

References

Page 22: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

References (cont)

Page 23: Clinical Challenges in the Patient With Relapsed Multiple Myeloma

References (cont)